Know Labs is developing a device that uses radiofrequency waves and artificial intelligence to interrogate and measure blood glucose levels in patients.
“Each and every molecule/analyte possesses a unique frequency at which it ‘excites’ or ‘resonates,’” Know Labs’ CEO Ron Erickson explained...